Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry Avorn

Showing results (161-170 of 436) with videos related to

Pageof 44
Sort By:
Hypertension (Dallas, Tex. : 1979)|July 1, 2004
Relationship between COX-2 specific inhibitors and hypertensionDaniel H Solomon, Sebastian Schneeweiss, Raisa Levin, et al.
JAMA Internal Medicine|November 22, 2017
Use of Health Care Databases to Support Supplemental Indications of Approved MedicationsMichael Fralick, Aaron S Kesselheim, Jerry Avorn, et al.
Journal of the American Geriatrics Society|May 25, 2002
Urinary antispasmodic use and the risks of ventricular arrhythmia and sudden death in older patientsPhilip S Wang, Raisa Levin, Sean Z Zhao, et al.
JAMA Network Open|April 30, 2021
Characteristics of Postmarketing Studies for Vaccines Approved by the US Food and Drug Administration, 2006-2020Osman Moneer, ChangWon C Lee, Jerry Avorn, et al.
Kidney International|August 13, 2003
Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgeryWolfgang C Winkelmayer, Robert J Glynn, Raisa Levin, et al.
Journal of Clinical Epidemiology|January 15, 2005
A Medicare database review found that physician preferences increasingly outweighed patient characteristics as determinants of first-time prescriptions for COX-2 inhibitorsSebastian Schneeweiss, Robert J Glynn, Jerry Avorn, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 25, 2006
Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarctionWolfgang C Winkelmayer, David M Charytan, Raisa Levin, et al.
Health Affairs (Project Hope)|February 5, 2014
Quantifying The Food And Drug Administration's rulemaking delays highlights the need for transparencyThomas J Hwang, Jerry Avorn, Daniel Carpenter, et al.
JAMA|March 16, 2016
Opioid Prescribing After Surgical Extraction of Teeth in Medicaid Patients, 2000-2010James A Baker, Jerry Avorn, Raisa Levin, et al.
American Journal of Epidemiology|August 19, 2010
Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation studyTil Stürmer, Kenneth J Rothman, Jerry Avorn, et al.
Pageof 44

Showing results (161-170 of 436) with videos related to

Sort By:
Pageof 44
Hypertension (Dallas, Tex. : 1979)|July 1, 2004
Relationship between COX-2 specific inhibitors and hypertensionDaniel H Solomon, Sebastian Schneeweiss, Raisa Levin, et al.
JAMA Internal Medicine|November 22, 2017
Use of Health Care Databases to Support Supplemental Indications of Approved MedicationsMichael Fralick, Aaron S Kesselheim, Jerry Avorn, et al.
Journal of the American Geriatrics Society|May 25, 2002
Urinary antispasmodic use and the risks of ventricular arrhythmia and sudden death in older patientsPhilip S Wang, Raisa Levin, Sean Z Zhao, et al.
JAMA Network Open|April 30, 2021
Characteristics of Postmarketing Studies for Vaccines Approved by the US Food and Drug Administration, 2006-2020Osman Moneer, ChangWon C Lee, Jerry Avorn, et al.
Kidney International|August 13, 2003
Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgeryWolfgang C Winkelmayer, Robert J Glynn, Raisa Levin, et al.
Journal of Clinical Epidemiology|January 15, 2005
A Medicare database review found that physician preferences increasingly outweighed patient characteristics as determinants of first-time prescriptions for COX-2 inhibitorsSebastian Schneeweiss, Robert J Glynn, Jerry Avorn, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 25, 2006
Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarctionWolfgang C Winkelmayer, David M Charytan, Raisa Levin, et al.
Health Affairs (Project Hope)|February 5, 2014
Quantifying The Food And Drug Administration's rulemaking delays highlights the need for transparencyThomas J Hwang, Jerry Avorn, Daniel Carpenter, et al.
JAMA|March 16, 2016
Opioid Prescribing After Surgical Extraction of Teeth in Medicaid Patients, 2000-2010James A Baker, Jerry Avorn, Raisa Levin, et al.
American Journal of Epidemiology|August 19, 2010
Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation studyTil Stürmer, Kenneth J Rothman, Jerry Avorn, et al.
Pageof 44